$21.64
+0 (+0%)
At Close: May 08, 2026
Form 8.3 - Avadel Pharmaceuticals plc
08:39am, Friday, 23'rd Jan 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 - Avadel Pharmaceuticals plc
08:37am, Monday, 19'th Jan 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 - Avadel Pharmaceuticals plc
09:22am, Thursday, 15'th Jan 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 - Avadel Pharmaceuticals plc
09:03am, Tuesday, 13'th Jan 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes
04:05pm, Monday, 12'th Jan 2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
Form 8.3 - Avadel Pharmaceuticals plc
10:08am, Friday, 09'th Jan 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 - Avadel Pharmaceuticals plc
08:22am, Thursday, 08'th Jan 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 - Avadel Pharmaceuticals plc
09:17am, Wednesday, 07'th Jan 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 - Avadel Pharmaceuticals plc
09:13am, Tuesday, 06'th Jan 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Avadel Pharmaceuticals PLC. $AVDL Shares Sold by Squarepoint Ops LLC
05:02am, Sunday, 21'st Dec 2025
Squarepoint Ops LLC reduced its stake in shares of Avadel Pharmaceuticals PLC. (NASDAQ: AVDL) by 49.6% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 13
Avadel Pharmaceuticals Announces Completion of Enrollment in Phase 3 REVITALYZ™ Trial in Idiopathic Hypersomnia
07:00am, Thursday, 18'th Dec 2025
- Data expected in Q2 2026 - DUBLIN, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, anno
Halper Sadeh LLC Encourages AVDL, CMA, KVUE Shareholders to Contact the Firm to Discuss Their Rights
01:18pm, Sunday, 14'th Dec 2025
NEW YORK, Dec. 14, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breac
AWM Investment Company Inc. Purchases 275,189 Shares of Avadel Pharmaceuticals PLC. $AVDL
03:50am, Saturday, 13'th Dec 2025
AWM Investment Company Inc. raised its position in Avadel Pharmaceuticals PLC. (NASDAQ: AVDL) by 671.2% during the undefined quarter, according to its most recent filing with the Securities and Exchan
Announcement relating to despatch of Rule 15 proposal
04:01pm, Friday, 05'th Dec 2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
Comparing Nuvilex (NASDAQ:PMCB) & Avadel Pharmaceuticals (NASDAQ:AVDL)
02:00am, Friday, 05'th Dec 2025
Avadel Pharmaceuticals (NASDAQ: AVDL - Get Free Report) and Nuvilex (NASDAQ: PMCB - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies b
Sign In
Buy AVDL